Ashish Mahendra
Overview
Explore the profile of Ashish Mahendra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jeys L, Morris G, Kurisunkal V, Botello E, Boyle R, Ebeid W, et al.
Bone Joint J
. 2025 Jan;
107-B(2):246-252.
PMID: 39889743
Aims: The Birmingham Orthopaedic Oncology Meeting (BOOM), held in January 2024, convened 309 delegates from 53 countries to discuss and refine 21 consensus statements on the optimal management of chondrosarcoma....
2.
Fraser E, Spence S, Farhan-Alanie O, Doonan J, Mahendra A, Gupta S
Bone Jt Open
. 2024 Dec;
5(12):1092-1100.
PMID: 39644918
Aims: Limb salvage surgery (LSS) is the primary treatment option for primary bone malignancy. It involves the removal of bone and tissue, followed by reconstruction with endoprosthetic replacements (EPRs) to...
3.
Jenkins J, Gupta S, Yahya A, Mahendra A, Balso C, Park S, et al.
J Foot Ankle Surg
. 2024 Oct;
64(1):79-85.
PMID: 39414126
Background: Osseous tumors of the foot and ankle are rarely encountered in general orthopaedic practice and represent only 3 % of osseous neoplasms. It can be difficult to distinguish between...
4.
Jenkins J, Gupta S, Mahendra A, Balso C, Park S, Daniels T, et al.
J Foot Ankle Surg
. 2024 Oct;
64(1):72-78.
PMID: 39369951
Fewer than 5 % of soft tissue sarcomas arise in the foot and ankle. It can be difficult to distinguish between benign and malignant lesions which leads to a delay...
5.
Jeys L, Thorkildsen J, Kurisunkal V, Puri A, Ruggieri P, Houdek M, et al.
Bone Joint J
. 2024 May;
106-B(5):425-429.
PMID: 38689572
Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of...
6.
Ansel S, Yan X, Chong P, Lo S, McCleery M, Mahendra A, et al.
J Med Case Rep
. 2023 Oct;
17(1):419.
PMID: 37798760
Background: This case reports the synchronous diagnosis of two rare unrelated diseases; leiomyosarcoma and tenosynovial giant cell tumor of the knee. It focuses on the challenges of diagnosing tenosynovial giant...
7.
Razii N, Docherty L, Halai M, Mahendra A, Gupta S
Curr Oncol
. 2023 May;
30(4):3697-3707.
PMID: 37185394
Benign and low-grade malignant bone tumours are often treated with curettage and filling of the resultant defect using any of a number of materials, including autologous bone grafts, allografts, or...
8.
Lo S, Childs C, Mahendra A, Young P, Carse B
J Plast Reconstr Aesthet Surg
. 2022 Sep;
75(11):3924-3937.
PMID: 36117134
Object: Limited objective evidence exists on the benefits of functional muscle transfers following quadriceps resection in sarcoma. In particular, no studies have compared patients with functional transfers to those without....
9.
Ben Gal O, Soh T, Vaughan S, Jayasanker V, Mahendra A, Gupta S
Curr Oncol
. 2022 Jul;
29(7):4703-4716.
PMID: 35877233
Individualized survival prognostic models for symptomatic patients with appendicular metastatic bone disease are key to guiding clinical decision-making for the orthopedic surgeon. Several prognostic models have been developed in recent...
10.
Shields D, Razii N, Doonan J, Mahendra A, Gupta S
Bone Jt Open
. 2021 Dec;
2(12):1049-1056.
PMID: 34905941
Aims: The primary objective of this study was to compare the postoperative infection rate between negative pressure wound therapy (NPWT) and conventional dressings for closed incisions following soft-tissue sarcoma (STS)...